register

News & Trends - Biotechnology

New partnership to advance genomic research in Australasia

Health Industry Hub | July 3, 2024 |

Biotech News: The Australian Genome Research Facility (AGRF) has entered a strategic partnership with US-based Dovetail Genomics.

As Australia’s non-profit genomic sequencing service provider, AGRF powers genomics through a national network of services and expertise. This collaboration is aimed at bolstering genomic research and innovation across Australia and New Zealand, launching AGRF as the premier provider of Dovetail’s cutting-edge products and services in the Australasian market.

Under this partnership, AGRF will offer Dovetail’s comprehensive 3D genomic portfolio of proximity ligation-based products, including Dovetail Omni-C, Micro-C, and the new family of LinkPrep Technology based products, TopoLink, AssemblyLink, and VariLink Kits. By integrating Dovetail’s proprietary technologies, AGRF will provide localised, high-quality genomic services, transforming the way researchers study the 3D genome.

This alliance not only redefines the accessibility and application of advanced genomics across various sectors, including biomedical, agri-genomics, and clinical research, but it also significantly enhances and expands AGRF’s service offerings.

Dr Mathew Easterday, CEO of Dovetail Genomics, shared his enthusiasm for the new strategic partnership, stating, “Our collaboration with AGRF is not just a partnership; it’s a powerful union that combines Dovetail’s cutting-edge technological platforms with AGRF’s extensive and robust service network to unlock new research opportunities in Australasia.

“Together, we are committed to advancing genomic research and setting new benchmarks for what can be achieved in the realms of biomedical, agricultural, and clinical research.”

The collaboration aligns with global industry trends as Hi-C technologies gain traction across a plethora of genomic applications and disease states.

Dr Cath Moore, Chief Scientific Officer at AGRF, elaborated on the significance of the partnership, stating, “3D genomics is transformative for researchers utilising AGRF’s genomic services. Unlocking the spatial mysteries of DNA; how it folds and loops and how that impacts gene regulation, cell differentiation, genome stability, and disease mechanisms.

“Bringing this capability to AGRF, and so to the Australian research community, provides a comprehensive understanding of genome function beyond linear DNA sequences, transforming our knowledge of cellular biology and disease mechanisms.”

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.